Save27%
Original price$ 21.95
Current price$ 15.95
SKU305732-451145
Get 24-hour relief from frequent heartburn with Nexium 24HR Tablets. It provides complete protection from frequent heartburn in easy-to-swallow tablets. Nexium 24HR tablets work by blocking acid directly at the source, giving you 24 hours of protection from frequent heartburn. Just one tablet a day provides all-day, all-night protection from frequent heartburn. Nexium 24HR is the #1 Selling OTC frequent heartburn brand.
How does it work?During prolonged heartburn, the acid in your heartburn attacks attacks attacks, causing the heart to pumps blood vessels hard enough for a triggered heartburn to occur. Nexium 24HR helps you — your sleep — by reducing interruptions due to frequent heartburn (4). It allude to frequent heartburn as a forgotten pill.
Add to known side effect: Nexium 24HR may cause some side effects includingheadache, inflammation, or stomach pain?Side effects not known.Talk to a doctor if you have specific concerns about these and other possible side effects.
There is no guarantee 24 hours after taking Nexium or any PPIs, PPIs, or other medicines, that your symptoms will subside. Most people take longer than four days for Nexium to work. Do not stop taking or skip doses.
Share your most recent experience with Nexium or any other PPIs, PPI’s, PPI’s without sharing it if you would like to learn more about the benefits and potential risks of taking Nexium. It is important to do so in a way that is safe and secure.
Get 24-hour relief from frequent heartburn with Nexium 24HR TabletsShop Over-the-Counter (OTC) Nexium online in no particular need with complete protection from frequent heartburn.When you shop with complete protection, you’ll save some money on your treatment. However, it’s important to ensure that you get the right treatment because over-the-counter access to Nexium is available without a prescription. To begin with, get the treatment you need right at the right time.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$35.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Protein(s)FrombadProduct informationThe product The Purple Pill is indicated for the treatment ofAcnein adult men. It is also used to treat other forms ofin adult men and adolescents. The Purple Pill is a synthetic form of theAcne Resistant AgentdrugAcid Resistant Agent. It has not been studied in children. If you are allergic to the contents of the Purple Pill, then no, it cannot be used in children under the age of 12. If your doctor has discussed with you whether this medication is safe and suitable for you with your healthcare professional, you will be considered a medical necessity (M4) Pharmacist Phone: 619-766-4357 Email: 514-543-6056 Phone: 514-543-5979 Pharmacy: 514-543-6079 Please discuss your preferences with your doctor before purchasing this medicine. Healthylife has taken all reasonable care to ensure that the product information provided is accurate, up to the time it was posted on the website. Product information has been extensively reviewed and updated by our team of medical experts since theoplesmedication.com.au website.oplesmedication.com.au has provided the product information to our team since theoplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.au.oplesmedication.com.Do not take esomeprazole, Naproxen, or proton pump inhibitor (omeprazole, rabeprazole, lansoprazole) within 2 weeks of stopping therapy with metformin or oral levothyroxine (thyroid hormones). These medications may increase your risk of cardiovascular (CV) thrombotic thrombotic systemic disease (asthma-like attack or attack with “ flare-ups” or other conditions) or serious muscle or cardiovascular disease (asthma-like disease). Ask your doctor or pharmacist if you have any questions about taking metformin or levothyroxine together.
Tell your doctor if you are pregnant, planning to become pregnant, or are breastfeeding.
Your doctor may prescribe you a lower dose of metformin (such as 500 mg once daily) or oral levothyroxine (such as 10 mcg twice daily).
Tell your doctor if you are taking anticoagulant (blood thinners) or mineral-restricted anticoagulants (such as warfarin). Your doctor may tell you not to take levothyroxine with metformin or mLODOSE (medroxy-sulphate) within 14 days of stopping therapy. Use of metformin and levothyroxine may increase your risk of GI bleeding or blood clots. Your doctor may tell you not to take metformin and levothyroxine together if you have had a stomach ulcer, perforation, or bleeding from a stomach or duodenal ulcer within the past 6 months (such as within the past 6 months, within the past 14 days, within the past 14 days, within the past 14 days). Your doctor may tell you not to take metformin and levothyroxine together if you have had a stomach ulcer within the past 6 months. Do not take any other medications that may interact with metformin or levothyroxine within the past 6 months.
Serious infectionsIf you develop severe or persistent abdominal pain, tenderness, or weakness during treatment, stop therapy and seek medical attention immediately. In the rare event of an infection, stop therapy and tell your doctor immediately. In the event of an infection, your doctor may tell you not to take metformin and levothyroxine together if you have had a stomach ulcer within the past 6 months. Do not take other medications that may interact with metformin or levothyroxine within the past 6 months. Ask your doctor or pharmacist for more details.
Tell your doctor or pharmacist if you are taking any other medications, especially any other medications or drugs that may interact with metformin or levothyroxine. These may include other NSAIDs (such as ibuprofen, naproxen, and diclofenac) or other antacids. Ask your doctor or pharmacist what other medications you are taking or if you have any questions about taking metformin or levothyroxine.
Tell your doctor or pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: aminoglycoside antibiotics (such as amikacin, gentamicin, or kanamycin), tacrolimus (such as atazanavir), telithromycin, and telaprevir; anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); corticosteroids such as prednisone (Immunosuppressant), tacrolimus (such as atazanavir), telithromycin (tacrolimus), and daclatate (for joint pain); and proton pump inhibitors such as esomeprazole (Nexium, Zegerid, others), lansoprazole (Prevacid, Zegerid), omeprazole (Prevacid X, Zegerid), pantoprazole (Protonix), and rabeprazole (AcipHep, Zegerid).
April 2, 2009
The Supreme Court of New York has recently ruled that AstraZeneca Pharmaceuticals Group Inc. Pfizer, United States may not be liable for its negligence in its marketing of Nexium, a prescription drug containing the active ingredient esomeprazole magnesium.
The plaintiff in the case, a New York-based multinational pharmaceutical firm, is AstraZeneca Pharmaceuticals Group Inc., a subsidiary of Pfizer Inc. The plaintiff has been developing a treatment for the long-term painkiller esomeprazole magnesium. The plaintiff claims that AstraZeneca wrongfully marketed the drug for esomeprazole magnesium.
The plaintiff, which owns U. S. trademark rights for Nexium, a prescription medication used for the treatment of chronic pain and inflammation, alleges that AstraZeneca knew or should have known that the product was not approved for use in New York in the United States, where the product is manufactured and sold in the United States.
In the ruling, the Supreme Court noted that the plaintiff's marketing of Nexium failed to satisfy the three-pronged test in the NDA for negligence, which the NDA requires.
The plaintiff's attorney argued that the NDA should not have been applied to AstraZeneca's products in New York, because the plaintiff's marketing was not sufficiently specific to the product in New York, and the NDA did not require the plaintiff's marketing of the product in New York.
The plaintiff did not reply to the argument by the plaintiff's attorney.
The Supreme Court of New York granted AstraZeneca's motion to dismiss the case, holding that the plaintiff did not meet the third and fourth prongs of the NDA. The plaintiffs claim that the NDA does not require the plaintiff to prove that the defendant's marketing was not adequate.
The plaintiff's attorney argued that the NDA does not require a plaintiff to prove that the defendant's marketing was sufficiently specific. The plaintiff's attorney did not present any evidence to support this argument in the record.
The Supreme Court of New York concluded that the plaintiff did not meet the third prong of the NDA. The plaintiff's attorney did not argue that the NDA did not require a plaintiff to prove that the defendant's marketing was sufficient.
The plaintiff's attorney argued that the NDA does not require a plaintiff to prove that the defendant's marketing was inadequate. The plaintiff's attorney did not present evidence to support this argument in the record. The plaintiff's attorney did not submit any evidence to support the argument in the record.
The plaintiff did not respond to the Court's motion to reconsider the issue of liability.
The plaintiff's attorney argued that the third prong of the NDA is not satisfied in this case because the plaintiff's marketing was sufficiently specific.
The plaintiff's attorney argued that the third and fourth prongs of the NDA fail to support the plaintiff's claim for negligent or intentional negligence.
The plaintiff's attorney argued that the NDA does not require a plaintiff to prove that the defendant's marketing was adequate.